Seeking Alpha: Betting Big on GNC

Michael Wiggins De Oliveira, author at Seeking Alpha, discusses health supplement retailer GNC as his "Idea of the Month." He notes that even though the company is in debt by more than $1 billion, it's still a buy for him because of the measures the company is taking to wipe out the debt, including the $200 million in annual free cash flow.

More In Business

How Insomnia Cookies Turned Late-Night Cravings into a Global Business

What started in a college dorm is now a cookie empire. Insomnia Cookies CEO Seth Berkowitz talks scale, strategy, and staying sweet.

'Returnuary' Exposed: The Tech Company Saving Millions of Returned Products

Billions of pounds of returns go to waste each year. REBEL CEO, Emily Hosie, on the company working to turn that waste into resale opportunity.

Rebuilding Wall Street on the Blockchain: Inside NANT Global Finance

NANT Global Finance CEO Mark Elenowitz shares how blockchain is transforming capital markets with integrated brokerage, exchange, and transfer services.

Big Business This Week: The $180 Billion gamble on Venezuela’s oil

Experts are finding it hard to see how the plan to exploit Venezuela’s oil makes business sense.

Meet the Company Powering America’s Autonomous Deliveries

Ali Kashani, CEO of Serve Robotics, explains how 2,000 AI-powered robots are transforming last-mile delivery across major U.S. cities.

Trailers don’t provide the viral marketing the studios believe they do

Trailers are turning into huge productions by themselves.

Are Parents Ready for Skyrocketing Childcare in 2026?

Taylor Bowley, Economist at Bank of America, details why childcare costs outpacing inflation may force tough financial trade-offs for U.S. families.

How Venezuela’s Oil Comeback Could Rewrite U.S. Energy Independence

Jay Hatfield, CEO/CIO of Infrastructure Capital Advisors, weighs in on how heavy crude may reshape U.S. refineries and energy equities.

How Retail Investors May Be Rewriting the Rules of the Market

As markets hit record highs amid volatility, eToro U.S. Head Andrew McCormick breaks down how retail investor behavior is rapidly evolving.

Inside Novo Nordisk’s Boldest Move Yet: A Weight-Loss Pill for the Masses

Daniel Gilbert, Business of Medicine Reporter at The Washington Post, breaks down Novo’s first GLP-1 weight-loss pill and why it matters.

Load More